COO (The Cooper Companies, Inc.) Return on Gross Profit

Corporate emblem and logo of The Cooper Companies, Inc. (COO)

High barriers to entry due to patent protection and complex certification make The Cooper Companies (COO) business resilient. The gross profit margin on the GURU.Markets base chart visualizes cost dynamics, where the value 61.40 reflects the current magnitude. Despite regulatory pressure and currency risks, the company maintains pricing power, easily passing costs onto consumers due to low demand elasticity.

coopercos.com (COO) Gross Profitability: for the period 07/04/2022 - 11/20/2026

Financial and market metric breakdowns for The Cooper Companies, Inc. (COO)

- current quotes and average value forecast:
- business market valuation indicators:
Basic company analysis:COO (CooperVision)
Manufactured products of CooperCompanies

Gross margin determines the share of profit after deducting direct production costs from total revenue. Analyzing the target gross margin allows for an assessment of the efficiency of cost management and pricing. The metric is calculated as the ratio of gross profit to sales, demonstrating the fundamental profitability of operations. For The Cooper Companies (COO), high margins confirm the commercial value of unique silicone-hydrogel structures and innovations in myopia correction.

Key competitors

BSX - Return on Sales by Gross Profit|EW (Edwards) - Gross Margin|Return on Gross Profit ResMed Corp (RMD)|Gross Margin PODD|Gross Margin zimmerbiomet.com (ZBH)|Gross Margin ALGN (aligntech.com)|Gross Margin Globus Medical Inc GMED|TMDX - Gross Profitability|ATEC: Gross Profitability|AORT (Artivion, Inc.) - Return on Gross Profit|Enovis Corporation - Gross Profit Rate|IART (Integra LifeSciences Inc.) - Gross Margin|Gross Profit Margin Establishment Labs Corp ESTA|Gross Profitability Beta Bionics, Inc. (BBNX)|IRADIMED CORPORATION (IRMD) - Gross Sales Margin|Embecta Health - Return on Gross Profit|Gross Margin Tandem Diabetes Care TNDM|AxoGen Inc - Gross Margin|Return on Sales by Gross Profit SI-BONE Inc SIBN|Orthofix (OFIX) - Gross Profitability|Return on Gross Profit Bioventus Corp|Gross Profitability orthopediatrics.com|Return on Gross Profit Treace Medical Concepts (TMCI)|Gross Margin SRTA|CARL - Gross Profit Margin|Gross Profitability RxSight, Inc. RXST|CLPT: Gross Return on Sales|STXS: Return on Gross Profit|neurostar.com - Gross Profit Ratio|Sight Sciences Inc. (SGHT) - Gross Profitability|Gross Profit Margin orchestrabiomed.com (OBIO)|Gross Profitability Anika Therapeutics, Inc.|Gross Return on Sales NSPR (InspireMD Inc.)|Gross Profitability Jin Medical International Ltd (ZJYL)|Gross Profitability VANI (Vivani Medical)|Gross Profitability xtantmedical.com XTNT|Gross Profit Rate NMTC|MODD - Gross Profitability|Gross Profit Rate MYO (Myomo, Inc)|COCH (Envoy Medical, Inc.) - Return on Gross Profit|Vivos Therapeutics, Inc. - Gross Profit Rate|Gross Profitability enVVeno Corp|SINT (Sintx Technologies) - Gross Profit Ratio|Gross Margin TNON|LFWD (Lifeward Ltd.) - Gross Profit Rate|autonomix.com - Return on Gross Profit|Return on Sales by Gross Profit invobioscience.com (IVF)|BBLG - Gross Profitability|AXNX (Axonics) - Gross Return on Sales|BIOL: Gross Margin|DYNT - Return on Sales by Gross Profit|FNA (paragon28.com) - Gross Margin|Gross Profit Margin invobioscience.com INVO